Anteris Technologies Limited is an Australian biotechnology company.
| Formerly |
|
|---|---|
| Company type | Public |
| ASX: AVR | |
| Industry | Biotechnology |
| Headquarters | , Australia |
| Website | anteristech |
History
editAnteris originates from the merger of Allied Medical and BioMD. Allied Medical was a company spun out of mining company Fortescue Metals Group in 2005 which focused on selling medical equipment such as catheters.[1] It entered the biotechnology space in July 2010 when it purchased a 38.6 per cent stake in Brisbane-based Coridon for A$3 million.[2] By February 2011, its stake increased to 55 per cent.[3] In February 2011, Allied Medical agreed to a reverse takeover deal with BioMD, a listed biotech company.[3] The takeover was completed in June 2011 resulting in the combined company, Allied Healthcare Group, listing on the Australian Securities Exchange (ASX).[4][5][6]
In September 2012, Allied raised $10.4 million to launch CardioCel across Europe.[7] In November 2013, Allied Healthcare changed its name to Admedus.[8] In December 2013, Admedus purchased a manufacturing site in Malaga to scale-up production of CardioCel and support the development and manufacture of additional regenerative tissue products.[7]
In October 2019, Admedus sold its CardioCel and VascuCel patch business to U.S.-based LeMaitre Vascular.[9] Under the agreement, Admedus received A$22.8 million upfront followed by deferred payments of $1 million each at 12 months and at 36 months. Additionally, the company could receive up to $11.4 million in earn-out payments.[10] Admedus retained the right to manufacture CardioCel and VascuCel products at its Malaga facility for LeMaitre over the following three years.[9] In May 2020, Admedus changed its name to Anteris Technologies.[11]
References
edit- ^ Thomson, James (18 July 2010). "Medical company backed by mining billionaire Andrew Forrest launches biotech investment push". SmartCompany. Retrieved 14 March 2023.
- ^ Greenblat, Eli (18 July 2010). "Mining magnate invests in biotech". The Sydney Morning Herald. Retrieved 15 March 2023.
- ^ a b Evans, Nick (15 February 2011). "Forrest biotech company to list". PerthNow. Retrieved 15 March 2023.
- ^ Evans, Nick (31 May 2011). "BioMD's Allied takeover wrapping up soon". PerthNow. Retrieved 15 March 2023.
- ^ Stafford, Patrick (20 June 2011). "Andrew Forrest-backed biotech lists on ASX". SmartCompany. Archived from the original on 24 June 2011. Retrieved 15 March 2023.
- ^ "bioMD Limited Makes Offer for Unlisted Allied Medical to Create Diversified Healthcare Group" (Press release). BioSpace. 15 February 2011. Retrieved 16 March 2023.
- ^ a b Drummond, Cameron (12 December 2013). "Biotech company buys manufacturing facility". Business News. Retrieved 15 March 2023.
- ^ Smith, Sean (21 November 2013). "Allied rebrands as Admedus". The West Australian. Retrieved 15 March 2023.
- ^ a b "Admedus sells its CardioCel and VascuCel patch business for $A36.2m". Australian Manufacturing. 16 October 2019. Retrieved 15 March 2023.
- ^ Ford, Omar (14 October 2019). "Admedus Turns Attention to TAVR Program". mddionline.com. Retrieved 15 March 2023.
- ^ Anderson, Caitlin (21 February 2023). "Med-device company Anteris Technologies raises $24 million". www.bizjournals.com. Retrieved 8 August 2024.